These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33652465)

  • 41. [Neuropsychological profile in patients with myotonic dystrophy type 1: a four-year follow-up study].
    Díaz-Leiva J; Cabada-Giadás T; Seijas-Gómez R; Jericó-Pascual I; López-Sala P; Iridoy-Zulet M
    Rev Neurol; 2020 Jun; 70(11):406-412. PubMed ID: 32436207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does quantitative EMG differ myotonic dystrophy type 2 and type 1?
    Szmidt-Salkowska E; Gawel M; Lusakowska A; Nojszewska M; Lipowska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    J Electromyogr Kinesiol; 2014 Oct; 24(5):755-61. PubMed ID: 25052913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1.
    Baldanzi S; Cecchi P; Fabbri S; Pesaresi I; Simoncini C; Angelini C; Bonuccelli U; Cosottini M; Siciliano G
    Neuroimage Clin; 2016; 12():190-7. PubMed ID: 27437180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multidimensional aspects of pain in myotonic dystrophies.
    Peric M; Peric S; Rapajic N; Dobricic V; Savic-Pavicevic D; Nesic I; Radojicic S; Novakovic I; Lavrnic D; Rakocevic-Stojanovic V
    Acta Myol; 2015 Dec; 34(2-3):126-32. PubMed ID: 27199540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
    Meola G
    Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.
    Wenninger S; Stahl K; Montagnese F; Schoser B
    Eur Neurol; 2020; 83(5):523-533. PubMed ID: 33120389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A descriptive study of the neuropsychological and psychopathological profile in patients with type 1 myotonic dystrophy].
    Seijas-Gomez R; Basterra-Jimenez I; Luna-Lario P; Tirapu-Ustarroz J; Cabada-Giadas T; Iridoy-Zulet M; Jerico-Pascual I; Gargallo-Vaamonde Á; Lopez-Goni JJ
    Rev Neurol; 2015 Dec; 61(12):529-35. PubMed ID: 26662870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A 5-year follow-up study of an atypical case of myotonic dystrophy.
    Macniven JA; Graham NL; Davies RR; Wilson BA
    Brain Inj; 2005 Dec; 19(14):1213-21. PubMed ID: 16286337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.
    Meola G; Cardani R
    Neurol Sci; 2017 Apr; 38(4):535-546. PubMed ID: 28078562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Personality traits in patients with myotonic dystrophy type 2.
    Paunic T; Peric S; Parojcic A; Savic-Pavicevic D; Vujnic M; Pesovic J; Basta I; Lavrnic D; Rakocevic-Stojanovic V
    Acta Myol; 2017 Mar; 36(1):14-18. PubMed ID: 28690389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Value of short exercise and short exercise with cooling tests in the diagnosis of myotonic dystrophies (DM1 and DM2).
    Gawel M; Szmidt-Salkowska E; Lusakowska A; Nojszewska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    Muscle Nerve; 2014 Feb; 49(2):277-83. PubMed ID: 23716346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires.
    Romigi A; Albanese M; Placidi F; Izzi F; Liguori C; Marciani MG; Mercuri NB; Terracciano C; Vitrani G; Petrucci A; Di Gioia B; Massa R
    Eur J Neurol; 2014 Jun; 21(6):929-34. PubMed ID: 23837695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of EEG-based functional brain networks in myotonic dystrophy type 1.
    Biere J; Okkersen K; van Alfen N; Kessels RPC; Gouw AA; van Dorst M; van Engelen B; Stam CJ; Raaphorst J;
    Clin Neurophysiol; 2020 Aug; 131(8):1886-1895. PubMed ID: 32590320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2.
    Bianchi ML; Losurdo A; Di Blasi C; Santoro M; Masciullo M; Conte G; Valenza V; Damiani A; Della Marca G; Silvestri G
    Sleep Breath; 2014 Sep; 18(3):579-89. PubMed ID: 24310756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient Input to Inform the Development of Central Nervous System Outcome Measures in Myotonic Dystrophy.
    White M
    Ther Innov Regul Sci; 2020 Sep; 54(5):1010-1017. PubMed ID: 31970692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.
    Romigi A; Franco V; Placidi F; Liguori C; Rastelli E; Vitrani G; Centonze D; Massa R
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):102. PubMed ID: 30382420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Body composition analysis in patients with myotonic dystrophy types 1 and 2.
    Peric S; Bozovic I; Nisic T; Banovic M; Vujnic M; Svabic T; Pesovic J; Brankovic M; Basta I; Jankovic M; Savic-Pavicevic D; Rakocevic-Stojanovic V
    Neurol Sci; 2019 May; 40(5):1035-1040. PubMed ID: 30790082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study.
    Modoni A; Silvestri G; Vita MG; Quaranta D; Tonali PA; Marra C
    J Neurol; 2008 Nov; 255(11):1737-42. PubMed ID: 18821050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.